Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Grover

Showing results (41-50 of 132) with videos related to

Pageof 14
Sort By:
Cardiovascular Drug Reviews|August 3, 2001
Ifetroban sodium: an effective TxA2/PGH2 receptor antagonistL Rosenfeld, G J Grover, C T Stier
The American Journal of Physiology|January 1, 1996
Comparative cardioprotective effects of cromakalim and diltiazem in ischemic hypertrophied rat heartsG J Grover, S Dzwonczyk, T M Monticello
Journal of Cardiovascular Pharmacology|November 1, 1990
Ruthenium red improves postischemic contractile function in isolated rat heartsG J Grover, S Dzwonczyk, P G Sleph
Pharmacology|January 1, 1990
Direct myocardial effects of the thromboxane A2/prostaglandin H2 agonists U-46619 and SQ 26,655 under ischemic and nonischemic conditionsG J Grover, A Hedberg, M L Ogletree
European Journal of Pharmacology|August 11, 1994
The effect of alpha 2-adrenoceptor antagonists in isolated globally ischemic rat heartsC A Sargent, S Dzwonczyk, G J Grover
Circulation|October 1, 1992
Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1-receptorsG J Grover, P G Sleph, S Dzwonczyk
The American Journal of Physiology|March 1, 1984
Effect of T4-induced cardiac hypertrophy on O2 supply-consumption balance during normoxia and hypoxiaK Talafih, G J Grover, H R Weiss
The Journal of Surgical Research|October 1, 1991
Thromboxane A2 receptor blockade improves contractile function following cardiopulmonary bypass in dogs and pigsN Kulatilake, L Gonzalez-Lavin, G J Grover
Cardiovascular Research|November 1, 1992
Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoateJ A Auchampach, G J Grover, G J Gross
Basic Research in Cardiology|March 1, 1991
The cardioprotective effects of the thromboxane receptor antagonist SQ 30,741 are not reversed by aspirinG J Grover, C S Parham, W A Schumacher
Pageof 14

Showing results (41-50 of 132) with videos related to

Sort By:
Pageof 14
Cardiovascular Drug Reviews|August 3, 2001
Ifetroban sodium: an effective TxA2/PGH2 receptor antagonistL Rosenfeld, G J Grover, C T Stier
The American Journal of Physiology|January 1, 1996
Comparative cardioprotective effects of cromakalim and diltiazem in ischemic hypertrophied rat heartsG J Grover, S Dzwonczyk, T M Monticello
Journal of Cardiovascular Pharmacology|November 1, 1990
Ruthenium red improves postischemic contractile function in isolated rat heartsG J Grover, S Dzwonczyk, P G Sleph
Pharmacology|January 1, 1990
Direct myocardial effects of the thromboxane A2/prostaglandin H2 agonists U-46619 and SQ 26,655 under ischemic and nonischemic conditionsG J Grover, A Hedberg, M L Ogletree
European Journal of Pharmacology|August 11, 1994
The effect of alpha 2-adrenoceptor antagonists in isolated globally ischemic rat heartsC A Sargent, S Dzwonczyk, G J Grover
Circulation|October 1, 1992
Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1-receptorsG J Grover, P G Sleph, S Dzwonczyk
The American Journal of Physiology|March 1, 1984
Effect of T4-induced cardiac hypertrophy on O2 supply-consumption balance during normoxia and hypoxiaK Talafih, G J Grover, H R Weiss
The Journal of Surgical Research|October 1, 1991
Thromboxane A2 receptor blockade improves contractile function following cardiopulmonary bypass in dogs and pigsN Kulatilake, L Gonzalez-Lavin, G J Grover
Cardiovascular Research|November 1, 1992
Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoateJ A Auchampach, G J Grover, G J Gross
Basic Research in Cardiology|March 1, 1991
The cardioprotective effects of the thromboxane receptor antagonist SQ 30,741 are not reversed by aspirinG J Grover, C S Parham, W A Schumacher
Pageof 14